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Abstract
Innate immune cells have recently been identified as novel thyroid hormone (TH) 
target cells in which intracellular TH levels appear to play an important functional role. 
The possible involvement of TH receptor alpha (TRα), which is the predominant TR in 
these cells, has not been studied to date. Studies in TRα0/0 mice suggest a role for this 
receptor in innate immune function. The aim of this study was to determine whether 
TRα affects the human innate immune response. We assessed circulating interleukin-8 
concentrations in a cohort of 8 patients with resistance to TH due to a mutation of 
TRα (RTHα) and compared these results to healthy controls. In addition, we measured 
neutrophil and macrophage function in one of these RTHα patients (mutation D211G). 
Circulating interleukin-8 levels were elevated in 7 out of 8 RTHα patients compared to 
controls. These patients harbor different mutations, suggesting that this is a general 
feature of the syndrome of RTHα. Neutrophil spontaneous apoptosis, bacterial killing, 
NAPDH oxidase activity and chemotaxis were unaltered in cells derived from the 
RTHαD211G patient. RTHα macrophage phagocytosis and cytokine induction after 
LPS treatment were similar to results from control cells. The D211G mutation did not 
result in clinically relevant impairment of neutrophil or pro-inflammatory macrophage 
function. As elevated circulating IL-8 is also observed in hyperthyroidism, this 
observation could be due to the high-normal to high levels of circulating T3 found in 
patients with RTHα.
Introduction
Thyroid hormone (TH) is essential for normal growth 
and development and largely exerts its biological actions 
through binding to nuclear thyroid hormone receptors 
(1). Thyroid hormone receptors (TRs) are encoded by 
the thyroid hormone receptor α and thyroid hormone 
receptor β genes (THRA and THRB, respectively), which 
can be alternatively spliced into several isoforms that are 
differentially expressed in various tissue and cell types (2). 
The two main isoforms of TRα are TRα1, which is a classic 
ligand-binding receptor and TRα2 which is not capable 
of binding triiodothyronine (T3) and whose function is 
not yet clear (2). TRα1 is the predominant isoform in 
cardiac and skeletal muscle, the central nervous system, 
bone and inflammatory cells (3, 4, 5, 6, 7, 8, 9). There are 
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two ligand-binding TRβ isoforms: TRβ1, which is mainly 
present in the brain, liver and kidney, and TRβ2, which is 
expressed in the hypothalamus and pituitary (1, 2).
Patients with resistance to TH due to mutations in 
TRβ (RTHβ) were first characterized decades ago. The first 
patients with inactivating mutations of the TH receptor α 
(TRα) were only recently identified (10, 11). Since then, 14 
different mutations in the THRA gene that result in RTHα 
have been described to date (10, 11, 12, 13, 14, 15, 16, 17, 
18, 19). Despite normal to only slightly abnormal plasma 
TH levels, clinical symptoms in these patients indicate 
resistance to TH at the tissue level including growth 
retardation, delayed bone development, constipation and 
cognitive defects (20). The severity of this phenotype is 
variable due to the heterogeneity of the underlying THRA 
mutations and their varying resultant loss of receptor 
function (12). The incidence of RTHα is expected to be 
similar to that of RTHβ, which is estimated to be around 
1:40,000, due to the high degree of homology between 
the receptors (21).
Neutrophils and macrophages are both important 
phagocytic cells of the innate immune system. Neutrophils 
are the most abundant circulating leukocytes and, as 
the first cells to migrate to the site of infection, play an 
essential role in bacterial killing (22, 23). Macrophages are 
essential for the recruitment of other immune cells and 
can shape the immune response by eliciting either a pro-
inflammatory or an anti-inflammatory reaction (24). Both 
neutrophils and macrophages are known to express TRα1 
and other molecular elements of TH metabolism, including 
deiodinase enzymes (5, 6). Furthermore, intracellular TH 
metabolism has been linked to the immune function of 
these cells (25). Mice that lack TRα have higher levels of 
circulating pro-inflammatory cytokines at baseline (26), 
excessive secretion of pro-inflammatory cytokines by 
unstimulated macrophages (26, 27), a lower induction of 
the pro-inflammatory cytokine granulocyte-macrophage 
colony-stimulating factor (GM-CSF) during acute 
inflammation (5) and impaired macrophage function in 
an atherosclerosis model (26). These studies indicate that 
intracellular TH levels appear to play an important role 
in the function of innate immune cells. The mechanism 
behind these effects is currently unknown and is possibly 
mediated via the predominant TR in these cells: TRα.
Although THs do appear to affect immune function at 
the cellular level (25), the effect of hypothyroidism on the 
immune response in patients is not entirely clear. A number 
of studies suggest that hypothyroidism impairs the innate 
immune response (28, 29, 30); however, others have also 
described an increase in circulating pro-inflammatory 
cytokines in hypothyroid patients (31). Furthermore, T3 
and T4 concentrations were positively correlated with 
several markers of inflammation in healthy euthyroid 
patients (32). The precise effects of altered thyroid status 
on the immune response in vivo remain to be determined.
The aim of this study is to determine whether TRα 
plays a role in the human innate immune response. To 
answer this, we assessed circulating pro-inflammatory 
cytokine levels in a previously described patient with RTHα 
(19) and found elevated concentrations of interleukin-8 
(IL-8). We then measured IL-8 in a larger cohort of 8 RTHα 
patients, all of whom have been previously described 
(18, 19). To further study the role of TRα in specific innate 
immune cells, we measured neutrophil and macrophage 
function in a single RTHα patient and compared these 
results to healthy controls. This patient was identified 
after his daughter was found to be a carrier of a novel TRα 
mutation as described in a recent paper by van Gucht and 
coworkers (19). The patient was the only RTHα patient in 
our cohort who was not being treated with l-thyroxine at 
the time of study, which is important as the resistance of 
TRα to T3 can be overcome by high doses of T3 in the case 
of this mutation (19). The RTHα patients described here 
present a unique opportunity to determine whether a lack 
of TRα affects innate immune function in humans.
Materials and methods
Patients and controls
Sera from 8 previously described RTHα patients (18, 19) 
were obtained following written informed consent. These 
patients included two patients (one adult and one pediatric 
patient) with RTHαD211G as previously described by van 
Gucht and coworkers (19), 4 patients with RTHαA263S 
and 2 patients with RTHαR384H as previously described 
by Demir and coworkers, and van Gucht and coworkers 
(18, 19). With the exception of the adult RTHαD211G 
patient, all RTHα patients were undergoing treatment 
with l-thyroxine at the time of study. Neutrophil and 
macrophage function were assessed in cells derived from 
the adult RTHαD211G patient. This male patient (aged 
31 years at the time of investigation) was identified as a 
carrier of a missense mutation D211G in TRα1 and TRα2 
following the diagnosis of his daughter with the same 
mutation (19). The patient’s phenotype at diagnosis was 
reported previously (19). Briefly, the patient reported 
mild symptoms of tissue hypothyroidism including 
delayed puberty and constipation. Physical examination 
revealed coarse facies, macrocephaly, short stature and 
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increased BMI. Blood pressure, bone mineral density 
and neuropsychological function tests were normal. 
Thyroid function tests at baseline are listed in Table  1. 
At the initiation of this study, the patient had never 
been treated with l-thyroxine. The patient reported no 
history of frequent bacterial infections or other signs of 
impaired innate immune function. Venous blood was 
also obtained from 11 healthy volunteers (6 males and 5 
females, median age 29 years) following written informed 
consent. The study was approved by the Medical Ethical 
Committee of the Academic Medical Center Amsterdam 
in accordance with the principles of the Declaration of 
Helsinki (version Fortaleza, 2013).
Cytokine measurements
Circulating levels of IL-8 were measured in sera from 
all RTHα patients and controls using the Human 
IL-8 Quantikine ELISA kit (R&D Systems) according 
to manufacturer’s instructions with the following 
modifications: sample volume was 100 µL, incubation 
time was 3 h and the following points were added to the 
standard curve: 3.6, 7.7, 15.8 and 31.3 pg/mL. Samples 
were measured in duplicate and samples below the 
detection limit (7.7 pg/mL) were assigned a value of half 
the detection limit.
A panel of pro-inflammatory cytokines and 
chemokines (IL-1β, IL-6, TNF and IL-8) were measured in 
supernatant of stimulated macrophages and in plasma 
from the adult RTHαD211G patient and healthy controls 
using the Human Inflammatory Cytokine Cytometric 
Bead Array kit (BD Biosciences, Franklin Lakes, NJ, USA). 
Samples were run in triplicate on a FACS Calibur flow 
cytometer (BD Biosciences). All samples were measured in 
the same run. Data were analyzed using FlowJo software 
(version 10).
Cell isolation and culture
Neutrophils were isolated as described previously (33, 34). 
Briefly, heparinized venous blood was subjected to density 
gradient centrifugation over isotonic Percoll (1.076 g/mL). 
Peripheral blood mononuclear cells (PBMC’s) were 
collected and used for monocyte isolation (see below). 
The pellet containing erythrocytes and granulocytes was 
harvested. Following erythrocyte lysis, neutrophils were 
washed and re-suspended in HEPES-buffered medium 
(132 mM NaCl, 6 mM KCl, 1 mM CaCl2, 1 mM MgSO4, 
1.2 mM K2HPO4, 20 mM HEPES, 1 mg/mL glucose, and 
0.5% (wt/vol) human serum albumin, pH 7.4). Cells 
were kept at room temperature (RT) until use. Neutrophil 
purity was assessed using flow cytometry.
Monocytes were separated from PBMCs by positive 
selection using a MACS magnetic cell separation 
kit in combination with anti-CD14 magnetic beads 
(Miltenyi Biotec, Leiden, the Netherlands) according to 
manufacturer’s instructions. Monocytes were washed 
and re-suspended in differentiation medium (RPMI-1640 
medium (Lonza, Basel, Switzerland) with 2% human 
pooled AB serum (Sigma Aldrich), 2.5 ng/mL of human 
M-CSF (eBioscience, San Diego, CA, USA) and 10 U/mL of 
penicillin and streptomycin (Lonza) plated at 1 × 106/mL) 
(35). Cells were cultured at 37°C and 5% CO2 for 7 days. 
On day 7, differentiation medium was removed and cells 
were subsequently cultured in RPMI-1640 medium (Lonza) 
with 10% fetal calf serum. Macrophage differentiation 
was assessed visually. Macrophage purity was checked 
using flow cytometry.
Neutrophil bacterial killing
Neutrophil in vitro bacterial killing of Escherichia coli 
(strain ML-35) and Staphylococcus aureus (strain 502A) was 
measured as described previously (36, 37). Briefly, bacteria 
were grown aerobically at 37°C until logarithmic growth 
was reached. Bacteria were washed and re-suspended at 
an OD 600 of 1 (i.e. 109 bacteria/mL). After opsonization, 
bacteria were added to neutrophils at a ratio of 5:1 and 
incubated at 37°C for the indicated time period. At the 
desired time points, samples were taken and neutrophils 
were lysed in water (pH 11.0). Serial dilutions of lysates 
Table 1 Thyroid hormone parameters of the RTHα patient. 
Values outside the reference range are indicated in bold.
Variable Reference values Patient’s values
T4 70–150 nmol/L 85
fT4 10–23 pmol/L 10.1
T3 1.3–2.7 nmol/L 2.25
rT3 0.11–0.44 nmol/L 0.12
TSH 0.5–5.0 mE/L 1.60
T3/T4 (×100) 1.42–3.05 2.65
T3/rT3 3.1–13.0 18.75
Thyroglobulin 0–45 pmol/L 13
IGF-1 8–41 nmol/L 24
Hemoglobin 8.5–10.5 mmol/L 7.3
MCV 80–100 fL 98.2
Ferritin 25–300 μg/L 272
Reproduced, with permission, from van Gucht AL, Meima ME, Zwaveling-
Soonawala N, Visser WE, Fliers E, Wennink JM, Henny C, Visser TJ, Peeters 
RP & van Trotsenburg AS. Resistance to thyroid hormone alpha inan 
18-month-old girl: clinical, therapeutic, and molecular characteristics, 
Thyroid, 2016, vol 26, pages 338–346 (19).
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were plated and incubated at 37°C overnight after which 
colony-forming units (CFU) were counted from which the 
percentage of neutrophil bacterial killing was calculated. 
The bacterial killing assay with neutrophils from the 
TRα-deficient patient were run in parallel with a day 
control and compared to a preexisting database of healthy 
controls (n = 32 for E. coli and n = 36 for S. aureus).
Neutrophil NADPH oxidase activity and chemotaxis
Nicotinamide adenine dinucleotide phosphate-oxidase 
(NADPH oxidase) activity was measured as described 
previously (38). Briefly, extracellular hydrogen peroxidase 
(H2O2) release in response to stimuli was measured using 
the Amplex Red (10-acetyl-3,7-dihydroxyphenoxazine) 
Hydrogen Peroxidase Assay kit (Molecular Probes). 
Phorbol 12-myristate 13-acetate (PMA, 100 ng/mL), 
unopsonized zymosan (1 mg/mL), serum-treated zymosan 
(STZ, 1 mg/mL), platelet-activating factor (PAF, 1 μM) 
followed by formyl-Met-Leu-Phe (fMLP, 1 μM) were used 
as stimuli (all Sigma Aldrich). Fluorescence was measured 
at 30-s intervals for 20 min with the Infinite 200 PRO 
(Tecan, Mannedorf, Switzerland). Results were compared 
to a day control and to the normal range of historical 
controls (n = 162).
Neutrophil migration toward various chemotactic 
stimuli was measured using 3 µm pore-size Fluoroblock 
inserts (Corning), in a Falcon 24-well plate as described 
previously (39). Neutrophils were fluorescently labeled 
with calcein AM (Thermo Fisher Scientific) and the 
following stimuli were used: complement component 5a 
(C5a), interleukin 8 (IL-8) and PAF. Results were compared 
to a day control, and to the normal range of historical 
controls (n = 132).
Neutrophil apoptosis
Spontaneous apoptosis was assessed in freshly isolated 
unstimulated neutrophils. Cells were incubated in a 
shaking water bath at 37°C for up to 24 h. Samples were 
harvested at the appropriate time points and double stained 
for Annexin V and propidium iodide (both BD Biosciences) 
according to manufacturer’s instructions. Samples were 
acquired on a BD FACS Canto II flow cytometer, and data 
were analyzed using FlowJo software (v.10).
Macrophage phagocytosis
Differentiated macrophages were incubated in a 96-well 
plate (5 × 104/well) with opsonized pHrodo green zymosan 
BioParticles conjugate (Molecular Probes) for 2 h at 37°C. 
pHrodo is a fluorogenic dye that strongly increases in 
fluorescence as the pH of its surroundings decreases. 
Since the extracellular environment is at a neutral pH and 
the intraphagosomal environment is highly acidic, the 
amount of fluorescence generated is an indirect measure 
for the amount of phagocytosed particles. Fluorescence 
was quantified on a Varioskan Flash plate reader (Thermo 
Fisher Scientific).
Macrophage stimulation, RNA isolation and qPCR
Differentiated macrophages were incubated with or 
without 100 ng/mL lipopolysaccharide (LPS or bacterial 
endotoxin, Escherichia coli strain 055:B5; Sigma Aldrich) 
for 3 h after which medium was harvested for cytokine 
measurements (see below) and cells were processed 
for RNA isolation using the High Pure RNA isolation 
kit (Roche). cDNA was synthesized with equal RNA 
input using AMV Reverse Transcriptase enzyme with 
oligo d(T) primers (Roche). A cDNA synthesis reaction 
without reverse transcriptase was included as a control 
for genomic DNA contamination. Quantitative real-time 
PCR was carried out using the Lightcycler 480 (Roche) and 
SensiFAST SYBR No-ROX (Bioline, Taunton, MA, USA). 
Data were analyzed using LinReg software. The mean of 
the efficiency was calculated for each assay, and samples 
that deviated more than 0.05 of the efficiency mean value 
were excluded from the analysis (0–5%). Primer sequences 
for HPRT1 (hypoxanthine phosphoribosyltransferase 
1 (HPRT)), TNF (tumor necrosis factor α (TNFα)) and 
CXCL8 (interleukin-8 (IL-8)) were published previously 
(40, 41, 42, 43). Primer sequences for IL1B (interleukin-
1β (IL-1β)) and IL6 (interleukin-6 (IL-6)) were derived 
from the Harvard Primer Bank (numbers 221139821c1, 
27894305c1 and 224831235c1, respectively). Primers 
were newly designed for the reference gene EEF1A1 
(eukaryotic translation elongation factor 1 alpha 1; Ef1α1: 
forward primer 5′-TTTTCGCAACGGGTTTGCC-3′, reverse 
primer: 5′-TTGCCCGAATCTACGTGTCC-3′, annealing 
temperature 65°C). Calculated values were normalized 
using the geometric mean of the reference genes Ef1α1 
and HPRT.
Statistics
Statistical analysis was performed in GraphPad Prism, 
version 7.01. Differences in serum IL-8 levels between 
controls and RTHα patients were tested using an unpaired 
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Student’s t-test. P < 0.05 was considered significant. 
Due to the study design, it was not possible to test whether 
differences in neutrophil and macrophage function 
between the single RTHα patient, and the healthy controls 
were statistically significant. Instead, we determined 
whether the results from the RTHα patient were within 
the range of normal controls. If values were outside this 
range, control data were tested for normality using the 
Shapiro–Wilk test. In the case of normal distribution, 
a z-score was calculated for the RTHα values. Z-scores 
that were >1.96 or <−1.96 (significance levels for α = 0.05) 
are listed.
Results
RTHα leads to an increase in circulating 
IL-8 concentrations
Plasma levels of selected pro-inflammatory cytokines and 
chemokines were measured in samples from both healthy 
controls and the adult RTHαD211G patient. IL-1β, IL-6, 
TNF, IL12p70 and IL-10 were below the detection limit of 
our assay (2.5–5 pg/mL) in all samples. However, we were 
able to detect IL-8 in both plasma of healthy controls and 
plasma from the RTHα patient. Plasma IL-8 in the RTHα 
patient was found to be higher than that in the healthy 
control group.
Following this finding, we measured IL-8 in sera 
from a cohort of previously described RTHα patients 
with different causative mutations to determine whether 
increased circulating IL-8 was a general feature of RTHα 
or specific to the D211G mutation. In total, sera from 
7 additional patients were obtained. These patients 
included another patient with RTHαD211G as previously 
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Figure 1
Serum IL-8 levels are increased in RTHα. IL-8 concentrations were 
quantified using an ELISA in serum samples from RTHα patients (filled 
symbols, n = 8) and healthy controls (○, n = 8). CRP levels were measured 
in the same serum sample. The detection limit of the assay is indicated 
(7.7 pg/mL). Samples below this limit were assigned a value of half of the 
detection limit (3.85 pg/mL). CRP levels were within the normal range 
(<5 mg/L) in all samples with the exception of one RTHαR384H patient 
(indicated with gray arrow) who had a slightly elevated CRP of 7.8 mg/L 
without clinical signs of illness. The mean of the RTHα samples is 
indicated. The P value indicated represents an unpaired Student’s t-test.
Figure 2
RTHα neutrophils show unchanged bacterial 
killing and survival ex vivo. (A) and (B) Freshly 
isolated neutrophils were incubated with live 
opsonized E. coli (A) or S. aureus (B) at 37°C. 
Graphs indicate the remaining percentage of 
bacteria present at the indicated time points vs 
baseline levels. RTHα neutrophils were run in 
parallel with a day control. Previously acquired 
controls values are also shown. (C) and (D) Freshly 
isolated neutrophils were incubated at 37°C. 
Samples were taken at the indicated time points 
and double stained for Annexin V and propidium 
iodide, markers for apoptosis and cell death, 
respectively. The percentage of healthy cells (C) 
and the percentage of Annexin V-positive, or 
apoptotic, cells (D) are indicated over time.
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described by van Gucht and coworkers (19), 4 patients 
with RTHαA263S and 2 patients with RTHαR384H all as 
previously described by Demir and coworkers, and van 
Gucht and coworkers (18, 19). IL-8 was measured in all 
of the additional samples, together with samples from the 
original patient and controls. IL-8 was found to be below 
the detection limit in all healthy controls and significantly 
elevated in RTHα patients (Fig. 1). Both healthy controls 
and RTHα patients reported no signs of illness on the day 
of blood draw. C-reactive protein (CRP), a highly specific 
determinant of inflammation, was measured in the same 
serum sample in which IL-8 was measured. One RTHα 
patient had a slightly elevated CRP of 7.8 mg/L (Fig.  1, 
reference value: <5 mg/L). All the remaining controls and 
patients had CRP concentrations within the normal range.
Neutrophil survival, bacterial killing, H2O2 production 
and chemotaxis are unaffected in RTHα
To determine whether RTHα affected not only circulating 
cytokine levels, but also innate immune cell function, we 
measured neutrophil and macrophage function in the 
adult RTHαD211G patient and healthy controls.
Various important neutrophil effector functions were 
analyzed in neutrophils derived from the RTHαD211G 
patient and cells derived from healthy controls. 
Neutrophils with an inactivating TRα mutation were 
incubated with live E. coli and S. aureus and showed normal 
bacterial killing compared to a previously acquired dataset 
of controls and a day control run in parallel (Fig. 2A and 
B). Spontaneous neutrophil apoptosis (i.e. neutrophil 
lifespan) was also unchanged in RTHα neutrophils when 
compared to neutrophils derived from controls (Fig. 2C 
and D). The ability of RTHα neutrophils to migrate toward 
the chemotactic stimuli C5a, IL-8 and PAF was within 
the normal range, as was their ability to produce H2O2 
upon stimulation with various pro-inflammatory stimuli 
(Fig. 3). H2O2 production is a measure for NADPH oxidase 
activity, which is an essential component of the neutrophil 
bacterial killing machinery (23). In conclusion, RTHα in 
this patient does not result in changes in the ability of 
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Neutrophil H2O2 release and chemotaxis are unchanged in an RTHα 
patient. (A) Neutrophil hydrogen peroxide (H2O2) release in response to 
stimuli. STZ, serum-treated zymosan; PMA, phorbol 12-myristate 
13-acetate; PAF, platelet-activating factor; fMLP, formyl-Met-Leu-Phe. 
Mean ± s.d. is indicated for data from healthy controls. (B) Migration of 
fluorescently labeled neutrophils toward various chemotactic stimuli. C5a, 
complement component 5a; IL-8, interleukin 8; PAF, platelet-activating 
factor. Data are indicated in relative fluorescent units (RFU) per minute. 
Mean ± s.d. is indicated for data from healthy controls.
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Macrophage phagocytosis is unchanged in an RTHα patient. Macrophages 
from the RTHα patient (●) and healthy controls (○) were incubated with 
pHrodo-labeled zymosan (yeast particles) for 2 h at 37°C. pHrodo becomes 
fluorescent at a low pH such as that present in phagosomes. The fold 
increase in relative fluorescent units vs pHrodo-labeled zymosan alone is 
shown.
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Figure 5
Macrophage pro-inflammatory cytokine levels are unchanged at baseline and after LPS stimulation in an RTHα patient; Macrophages from the RTHα 
patient (●) and healthy controls (○) were incubated with or without LPS (100 ng/mL) for 3 h. Cytokine relative mRNA expression (A) and secreted protein 
concentrations (B) are depicted. For the RTHα patient results from two independent experiments are shown.
neutrophil to migrate toward, recognize, phagocytose and 
kill bacteria.
Pro-inflammatory macrophage function is not altered 
in RTHα
Several essential aspects of pro-inflammatory macrophage 
function were measured in macrophages derived 
from the RTHαD211G patient and healthy controls. 
Phagocytosis, determined by the cells ability to engulf 
fluorescent particles, was found to be unchanged in RTHα 
macrophages compared to control macrophages (Fig. 4). 
Macrophages were also stimulated with LPS, a bacterial cell 
wall component that acts as a strong pro-inflammatory 
stimulus. LPS stimulation resulted in a robust induction 
of the pro-inflammatory cytokines IL-1β, IL-6, TNFα and 
IL-8 at the transcriptional level (Fig. 5A) and at the protein 
level (Fig.  5B). The response in RTHα macrophages was 
within the range of healthy control cells, both at the 
transcriptional and at the secretory/protein level (Fig. 5).
Discussion
Innate immune cells have recently been identified as novel 
TH target cells (25). It is currently unknown whether the 
effects of TH in innate immune cells are mediated via TRα, 
the predominant TR isoform in these cells. The aim of this 
study is to determine whether TRα plays a role in innate 
immune function in humans. More insight into the effects 
of an inactivating TRα mutation can lead to improved 
future treatment of RTHα patients, and greatly increase 
the understanding of this syndrome and its clinical and 
physiological consequences. We are the first to study the 
effects of RTHα on innate immunity in humans.
We find elevated levels of circulating IL-8 in RTHα 
patients. IL-8, also known as CXCL8, is a potent pro-
inflammatory chemokine whose primary function 
is to recruit and activate inflammatory cells, mainly 
neutrophils, to the site of infection via a chemotactic 
gradient (44). IL-8 is expressed in humans, but there is no 
rodent equivalent (44). As IL-8 expression and secretion 
were not elevated in RTHα macrophages, the increase in 
circulating IL-8 is most likely due to increased production 
by another cell type. Interestingly, elevated circulating 
IL-8 levels have also been described in hyperthyroidism 
(both Graves’ disease and toxic multinodular goiter) 
(45). Furthermore, T3 induces IL-8 production in bone 
marrow stromal cells and a human osteoblast cell line 
(46), suggesting that the increase in circulating IL-8 could 
be a consequence of high circulating T3 concentrations, 
rather than a cause of autoimmune thyroid disease. 
RTHα patients tend to have high-normal to high levels 
of circulating T3 (12); this could potentially result in 
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increased levels of IL-8. As elevated IL-8 was observed in 
patients both on and off levothyroxine, it appears to be 
an effect of the underlying condition, not its treatment.
Intracellular TH metabolism is thought to play 
an important role in the bacterial killing abilities of 
neutrophils via the induction of type 3 deiodinase (D3) 
(6, 25, 47, 48, 49). The mechanism behind this remains 
unclear (25). One of the possibilities is that the modulation 
of intracellular T3 levels by D3 could result in an effect 
through changes in TR occupancy and subsequent 
T3-dependent gene transcription. TRα is the predominant 
receptor isoform in both neutrophils and macrophages 
(5, 6). In macrophages, intracellular T3 availability and 
action also appear to be important for pro-inflammatory 
function (5, 25). Our results in this patient suggest that 
the effects of intracellular TH metabolism on neutrophil 
and macrophage function are not mediated via the TRα. 
However, as the D211G mutation is a relatively mild 
mutation, in which TRα1 has reduced transcriptional 
activity which can be overcome by high concentrations 
of T3 (100 nM (19)), we cannot exclude the possibility that 
some transcriptional activity of the receptor is preserved in 
cells from this RTHα patient. Another possible explanation 
could be that the effects of T3 in these cells are mediated 
via pathways that do not require binding to the TR, such 
as the signaling pathway involving the plasma membrane 
integrin receptor avβ3 (50). Other authors have suggested 
that the effects of extracellular TH on macrophages are 
mediated via this receptor, resulting in the activation 
of the ERK1/2 and PI3K pathways (51). Whether these 
pathways could also be involved in intracellular TH 
signaling is currently unknown. 
Interestingly, macrophages derived from TRα0/0 
mice do exhibit altered function. TRα0/0 mice show 
deficient macrophage cholesterol efflux, increased aortic 
inflammation, elevated serum pro-inflammatory cytokine 
levels and increased macrophage pro-inflammatory 
cytokine expression and secretion (26, 27). However, we 
do not find changes in macrophage cytokine induction 
in human macrophages derived from an RTHα patient 
compared to healthy controls. This discrepancy could be 
due to the fact that TRα0/0 mice are completely deficient for 
TRα, whereas RTHα patients exhibit decreased sensitivity 
for T3 but retain the dominant negative activity of the 
receptor (52, 53).
The main limitation of the functional neutrophil 
and macrophage assays in this study is the fact that 
material from only one untreated RTHα patient was 
studied. The functional leukocyte assays using RTHα 
leukocytes were repeated independently yielding similar 
results; we therefore believe that the lack of phenotypical 
abnormalities in RTHα neutrophils and macrophages is 
consistent, at least in the case of the D211G mutation. 
However, as mutations resulting in RTHα are heterozygous, 
we cannot exclude that other TRα mutations, with for 
example, a more severe loss of receptor function, might 
affect leukocyte function. As leukocytes need to be isolated 
from heparinized venous blood within several hours after 
the blood draw, obtaining and analyzing cells from larger 
numbers of patients is logistically very complicated due 
to the very small number of currently available untreated 
RTHα patients. However, as we were able demonstrate 
elevated IL-8 in serum samples from a number of other 
RTHα patients harboring different mutations, we believe 
this considerably strengthens the study and confirms that 
increased IL-8 is a general feature of RTHα and not one 
limited to the D211G mutation.
Intracellular TH metabolism has been shown to be 
essential for adequate pro-inflammatory neutrophil and 
macrophage function, identifying innate immune cells 
as novel TH target cells (25). This study is the first to 
assess the role of TRα in human innate immune function. 
Our results show that RTHα results in an increase in 
circulating IL-8 levels, which has also been described in 
hyperthyroid patients and therefore might lead to a slight 
increase in circulating T3. Furthermore, we demonstrate 
that a relatively mild mutation in the TRα does not result 
in clinically relevant impairment of neutrophil or pro-
inflammatory macrophage function.
Declaration of interest
The authors declare that there is no conflict of interest that could be 
perceived as prejudicing the impartiality of the research reported.
Funding
This work was supported by the AMC Graduate School PhD Scholarship 
(A H v d S).
Author contribution statement
A H v d S, E F and A B designed the experiments. A H v d S, O V S, S A, A T 
J T, A v d G and A L M v G performed the experiments. K D and A S P v T 
provided patient material. T K v d B, E F and A B supervised experiments. A 
H v d S, E F and A B wrote the original draft of the manuscript. All authors 
read and approved the final version of the manuscript.
Acknowledgments
The authors would like to thank Alex de Vos (Center for Experimental 
and Molecular Medicine, AMC, Amsterdam) for providing expertise and 
technical support with cytokine measurements in human serum and cell 
supernatants.
This work is licensed under a Creative Commons 
Attribution 4.0 International License.
Research A H van der Spek et al. IL-8, neutrophil and 
macrophage function in RTHα
En
d
o
cr
in
e 
C
o
n
n
ec
ti
o
n
s
6:739739–740
DOI: 10.1530/EC-17-0213
http://www.endocrineconnections.org © 2017 The authors
Published by Bioscientifica Ltd
References
 1 Brent GA. Mechanisms of thyroid hormone action. Journal of Clinical 
Investigation 2012 122 3035–3043. (doi:10.1172/JCI60047)
 2 Cheng SY, Leonard JL & Davis PJ. Molecular aspects of thyroid 
hormone actions. Endocrine Reviews 2010 31 139–170. (doi:10.1210/
er.2009-0007)
 3 Wallis K, Dudazy S, van Hogerlinden M, Nordstrom K, Mittag J& 
Vennstrom B. The thyroid hormone receptor alpha1 protein 
is expressed in embryonic postmitotic neurons and persists in 
most adult neurons. Molecular Endocrinology 2010 24 1904–1916. 
(doi:10.1210/me.2010-0175)
 4 Bassett JH & Williams GR. The skeletal phenotypes of TRalpha and 
TRbeta mutant mice. Journal of Molecular Endocrinology 2009 42 
269–282. (doi:10.1677/JME-08-0142)
 5 Kwakkel J, Surovtseva OV, de Vries EM, Stap J, Fliers E & Boelen A. 
A novel role for the thyroid hormone-activating enzyme type 
2 deiodinase in the inflammatory response of macrophages. 
Endocrinology 2014 155 2725–2734. (doi:10.1210/en.2013-2066)
 6 van der Spek AH, Bloise FF, Tichgelaar W, Dentice M, Salvatore D, 
van der Wel NN, Fliers E & Boelen A. The thyroid hormone 
inactivating enzyme type 3 deiodinase is present in bactericidal 
granules and the cytoplasm of human neutrophils. Endocrinology 
2016 157 3293–3305. (doi:10.1210/en.2016-1103)
 7 Milanesi A, Lee JW, Kim NH, Liu YY, Yang A, Sedrakyan S, Kahng A, 
Cervantes V, Tripuraneni N, Cheng SY, et al. Thyroid hormone 
receptor alpha plays an essential role in male skeletal muscle 
myoblast proliferation, differentiation, and response to injury. 
Endocrinology 2016 157 4–15. (doi:10.1210/en.2015-1443)
 8 Bassett JH, Boyde A, Zikmund T, Evans H, Croucher PI, Zhu X, 
Park JW, Cheng SY & Williams GR. Thyroid hormone receptor alpha 
mutation causes a severe and thyroxine-resistant skeletal dysplasia 
in female mice. Endocrinology 2014 155 3699–3712. (doi:10.1210/
en.2013-2156)
 9 Macchia PE, Takeuchi Y, Kawai T, Cua K, Gauthier K, Chassande O, 
Seo H, Hayashi Y, Samarut J, Murata Y, et al. Increased sensitivity 
to thyroid hormone in mice with complete deficiency of thyroid 
hormone receptor alpha. PNAS 2001 98 349–354. (doi:10.1073/
pnas.011306998)
 10 Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, 
Rajanayagam O, Keogh JM, Henning E, Reinemund J, Gevers E, 
Sarri M, et al. A mutation in the thyroid hormone receptor 
alpha gene. New England Journal of Medicine 2012 366 243–249. 
(doi:10.1056/NEJMoa1110296)
 11 van Mullem A, van Heerebeek R, Chrysis D, Visser E, Medici M, 
Andrikoula M, Tsatsoulis A, Peeters R & Visser TJ. Clinical phenotype 
and mutant TRalpha1. New England Journal of Medicine 2012 366 
1451–1453. (doi:10.1056/NEJMc1113940)
 12 Moran C & Chatterjee K. Resistance to thyroid hormone alpha-
emerging definition of a disorder of thyroid hormone action. Journal 
of Clinical Endocrinology and Metabolism 2016 101 2636–2639. 
(doi:10.1210/jc.2016-2317)
 13 Moran C, Agostini M, Visser WE, Schoenmakers E, Schoenmakers N, 
Offiah AC, Poole K, Rajanayagam O, Lyons G, Halsall D, et al. 
Resistance to thyroid hormone caused by a mutation in thyroid 
hormone receptor (TR)alpha1 and TRalpha2: clinical, biochemical, 
and genetic analyses of three related patients. Lancet Diabetes and 
Endocrinology 2014 2 619–626. (doi:10.1016/S2213-8587(14)70111-1)
 14 Moran C, Schoenmakers N, Agostini M, Schoenmakers E, Offiah A, 
Kydd A, Kahaly G, Mohr-Kahaly S, Rajanayagam O, Lyons G, et 
al. An adult female with resistance to thyroid hormone mediated 
by defective thyroid hormone receptor alpha. Journal of Clinical 
Endocrinology and Metabolism 2013 98 4254–4561. (doi:10.1210/
jc.2013-2215)
 15 van Mullem AA, Chrysis D, Eythimiadou A, Chroni E, Tsatsoulis A, 
de Rijke YB, Visser WE, Visser TJ & Peeters RP. Clinical phenotype 
of a new type of thyroid hormone resistance caused by a mutation 
of the TRalpha1 receptor: consequences of LT4 treatment. Journal 
of Clinical Endocrinology and Metabolism 2013 98 3029–3038. 
(doi:10.1210/jc.2013-1050)
 16 Tylki-Szymanska A, Acuna-Hidalgo R, Krajewska-Walasek M, Lecka-
Ambroziak A, Steehouwer M, Gilissen C, Brunner HG, Jurecka A, 
Różdżyńska-Świątkowska A, Hoischen A, et al. Thyroid hormone 
resistance syndrome due to mutations in the thyroid hormone 
receptor alpha gene (THRA). Journal of Medical Genetics 2015 52 
312–316. (doi:10.1136/jmedgenet-2014-102936)
 17 Espiard S, Savagner F, Flamant F, Vlaeminck-Guillem V, Guyot R, 
Munier M, d'Herbomez M, Bourguet W, Pinto G, Rose C, et al. A 
novel mutation in THRA gene associated with an atypical phenotype 
of resistance to thyroid hormone. Journal of Clinical Endocrinology and 
Metabolism 2015 100 2841–2848. (doi:10.1210/jc.2015-1120)
 18 Demir K, van Gucht AL, Buyukinan M, Catli G, Ayhan Y, Nijat Bas V, 
Dündar B, Özkan B, Meima ME, Visser WE, et al. Diverse genotypes 
and phenotypes of three novel thyroid hormone receptor alpha 
mutations. Journal of Clinical Endocrinology and Metabolism 2016 101 
2945–2954. (doi:10.1210/jc.2016-140)
 19 van Gucht AL, Meima ME, Zwaveling-Soonawala N, Visser WE, 
Fliers E, Wennink JM, Henny C, Visser TJ, Peeters RP & van 
Trotsenburg AS. Resistance to thyroid hormone alpha in 
an 18-month-old girl: clinical, therapeutic, and molecular 
characteristics. Thyroid 2016 26 338–346. (doi:10.1089/
thy.2015.0463)
 20 Moran C & Chatterjee K. Resistance to thyroid hormone due to 
defective thyroid receptor alpha. Best Practice and Research Clinical 
Endocrinology and Metabolism 2015 29 647–657. (doi:10.1016/j.
beem.2015.07.007)
 21 Lafranchi SH, Snyder DB, Sesser DE, Skeels MR, Singh N, Brent GA 
& Nelson JC. Follow-up of newborns with elevated screening T4 
concentrations. Journal of Pediatrics 2003 143 296–301. (doi:10.1067/
S0022-3476(03)00184-7)
 22 Borregaard N. Neutrophils from marrow to microbes. Immunity 2010 
33 657–670. (doi:10.1016/j.immuni.2010.11.011)
 23 Kolaczkowska E & Kubes P. Neutrophil recruitment and function 
in health and inflammation. Nature Reviews Immunology 2013 13 
159–175. (doi:10.1038/nri3399)
 24 Murray PJ & Wynn TA. Protective and pathogenic functions of 
macrophage subsets. Nature Reviews Immunology 2011 11 723–737. 
(doi:10.1038/nri3073)
 25 van der Spek AH, Fliers E & Boelen A. Thyroid hormone metabolism 
in innate immune cells. Journal of Endocrinology 2017 232 R67–R81. 
(doi:10.1530/JOE-16-0462)
 26 Billon C, Canaple L, Fleury S, Deloire A, Beylot M, Dombrowicz D, 
Del Carmine P, Samarut J & Gauthier K. TRalpha protects against 
atherosclerosis in male mice: identification of a novel anti-
inflammatory property for TRalpha in mice. Endocrinology 2014 155 
2735–2745. (doi:10.1210/en.2014-1098)
 27 Furuya F, Ishii T, Tamura S, Takahashi K, Kobayashi H, Ichijo M, 
Takizawa S, Kaneshige M, Suzuki-Inoue K & Kitamura K. The ligand-
bound thyroid hormone receptor in macrophages ameliorates kidney 
injury via inhibition of nuclear factor-kappaB activities. Scientific 
Reports 2017 7 43960. (doi:10.1038/srep43960)
 28 Schoenfeld PS, Myers JW, Myers L & LaRocque JC. Suppression of 
cell-mediated immunity in hypothyroidism. Southern Medical Journal 
1995 88 347–349. (doi:10.1097/00007611-199503000-00019)
 29 Pillay K. Congenital hypothyroidism and immunodeficiency: 
evidence for an endocrine-immune interaction. Journal of Pediatric 
Endocrinology and Metabolism 1998 11 757–761.
 30 De Vito P, Balducci V, Leone S, Percario Z, Mangino G, Davis PJ, 
Davis FB, Affabris E, Luly P, Pedersen JZ, et al. Nongenomic 
effects of thyroid hormones on the immune system cells: new 
targets, old players. Steroids 2012 77 988–995. (doi:10.1016/j.
steroids.2012.02.018)
This work is licensed under a Creative Commons 
Attribution 4.0 International License.
Research A H van der Spek et al. IL-8, neutrophil and 
macrophage function in RTHα
En
d
o
cr
in
e 
C
o
n
n
ec
ti
o
n
s
6:740740–740
DOI: 10.1530/EC-17-0213
http://www.endocrineconnections.org © 2017 The authors
Published by Bioscientifica Ltd
 31 De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB & Davis PJ. Thyroid 
hormones as modulators of immune activities at the cellular level. 
Thyroid 2011 21 879–890. (doi:10.1089/thy.2010.0429)
 32 Hodkinson CF, Simpson EE, Beattie JH, O'Connor JM, Campbell DJ, 
Strain JJ & Wallace JM. Preliminary evidence of immune function 
modulation by thyroid hormones in healthy men and women aged 
55–70 years. Journal of Endocrinology 2009 202 55–63. (doi:10.1677/
JOE-08-0488)
 33 Kuijpers TW, Tool AT, van der Schoot CE, Ginsel LA, Onderwater JJ, 
Roos D & Verhoeven AJ. Membrane surface antigen expression on 
neutrophils: a reappraisal of the use of surface markers for neutrophil 
activation. Blood 1991 78 1105–1111.
 34 Roos D & de Boer M. Purification and cryopreservation of phagocytes 
from human blood. Methods in Enzymology 1986 132 225–243.
 35 Menck K, Behme D, Pantke M, Reiling N, Binder C, Pukrop T 
& Klemm F. Isolation of human monocytes by double gradient 
centrifugation and their differentiation to macrophages in teflon-
coated cell culture bags. Journal of Visualized Experiments 2014 91 
e51554. (doi:10.3791/51554)
 36 Decleva E, Menegazzi R, Busetto S, Patriarca P & Dri P. Common 
methodology is inadequate for studies on the microbicidal activity of 
neutrophils. Journal of Leukocyte Biology 2006 79 87–94. (doi:10.1189/
jlb.0605338)
 37 van Bruggen R, Drewniak A, Tool AT, Jansen M, van Houdt M, 
Geissler J, van den Berg TK, Chapel H & Kuijpers TW. Toll-like 
receptor responses in IRAK-4-deficient neutrophils. Journal of Innate 
Immunity 2010 2 280–287. (doi:10.1159/000268288)
 38 Szilagyi K, Gazendam RP, van Hamme JL, Tool AT, van Houdt M, 
Vos WA, Verkuijlen P, Janssen H, Belot A, Juillard L, et al. Impaired 
microbial killing by neutrophils from patients with protein kinase C 
delta deficiency. Journal of Allergy and Clinical Immunology 2015 136 
1404.e1–1407.e10. (doi:10.1016/j.jaci.2015.06.016)
 39 Kuijpers TW, van Bruggen R, Kamerbeek N, Tool AT, Hicsonmez G, 
Gurgey A, Karow A, Verhoeven AJ, Seeger K, Sanal O, et al. Natural 
history and early diagnosis of LAD-1/variant syndrome. Blood 2007 
109 3529–3537. (doi:10.1182/blood-2006-05-021402)
 40 Bouaboula M, Legoux P, Pessegue B, Delpech B, Dumont X, 
Piechaczyk M, Casellas P & Shire D. Standardization of mRNA 
titration using a polymerase chain reaction method involving 
co-amplification with a multispecific internal control. Journal of 
Biological Chemistry 1992 267 21830–21838.
 41 Sharif O, Bolshakov VN, Raines S, Newham P & Perkins ND. 
Transcriptional profiling of the LPS induced NF-kappaB  
response in macrophages. BMC Immunology 2007 8 1. 
(doi:10.1186/1471-2172-8-1)
 42 Chan SY, Franklyn JA, Pemberton HN, Bulmer JN, Visser TJ, 
McCabe CJ & Kilby MD. Monocarboxylate transporter 8 expression 
in the human placenta: the effects of severe intrauterine growth 
restriction. Journal of Endocrinology 2006 189 465–471. (doi:10.1677/
joe.1.06582)
 43 Liu J, Cao S, Herman LM & Ma X. Differential regulation of 
interleukin (IL)-12 p35 and p40 gene expression and interferon 
(IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. 
Journal of Experimental Medicine 2003 198 1265–1276. (doi:10.1084/
jem.20030026)
 44 Remick DG. Interleukin-8. Critical Care Medicine 2005 33 
(Supplement 12) S466–S467.
 45 Rotondi M, Coperchini F & Chiovato L. CXCL8 in thyroid disease: 
from basic notions to potential applications in clinical practice. 
Cytokine and Growth Factor Reviews 2013 24 539–546. (doi:10.1016/j.
cytogfr.2013.08.001)
 46 Siddiqi A, Burrin JM, Wood DF & Monson JP. Tri-iodothyronine 
regulates the production of interleukin-6 and interleukin-8 in 
human bone marrow stromal and osteoblast-like cells. Journal of 
Endocrinology 1998 157 453–461. (doi:10.1677/joe.0.1570453)
 47 Boelen A, Boorsma J, Kwakkel J, Wieland CW, Renckens R, Visser TJ, 
Fliers E & Wiersinga WM. Type 3 deiodinase is highly expressed in 
infiltrating neutrophilic granulocytes in response to acute bacterial 
infection. Thyroid 2008 18 1095–1103. (doi:10.1089/thy.2008.0090)
 48 Boelen A, Kwakkel J, Alkemade A, Renckens R, Kaptein E, Kuiper G, 
Wiersinga WM & Visser TJ. Induction of type 3 deiodinase activity 
in inflammatory cells of mice with chronic local inflammation. 
Endocrinology 2005 146 5128–5134. (doi:10.1210/en.2005-0608)
 49 Boelen A, Kwakkel J, Wieland CW, St Germain DL, Fliers E & 
Hernandez A. Impaired bacterial clearance in type 3 deiodinase-
deficient mice infected with Streptococcus pneumoniae. 
Endocrinology 2009 150 1984–1990. (doi:10.1210/en.2008-1133)
 50 Flamant F, Cheng SY, Hollenberg AN, Moeller LC, Samarut J, 
Wondisford FE, Yen PM & Refetoff S. Thyroid hormone signaling 
pathways: time for a more precise nomenclature. Endocrinology 2017 
158 2052–2057. (doi:10.1210/en.2017-00250)
 51 Chen Y, Sjolinder M, Wang X, Altenbacher G, Hagner M, Berglund P, 
Gao Y, Lu T, Jonsson AB & Sjölinder H. Thyroid hormone enhances 
nitric oxide-mediated bacterial clearance and promotes survival after 
meningococcal infection. PLoS ONE 2012 7 e41445. (doi:10.1371/
journal.pone.0041445)
 52 Gauthier K, Plateroti M, Harvey CB, Williams GR, Weiss RE, 
Refetoff S, Willott JF, Sundin V, Roux JP & Malaval L. Genetic 
analysis reveals different functions for the products of the thyroid 
hormone receptor alpha locus. Molecular and Cellular Biology 2001 21 
4748–4760. (doi:10.1128/MCB.21.14.4748-4760.2001)
 53 Ortiga-Carvalho TM, Sidhaye AR & Wondisford FE. Thyroid hormone 
receptors and resistance to thyroid hormone disorders. Nature Reviews 
Endocrinology 2014 10 582–591. (doi:10.1038/nrendo.2014.143)
Received in final form 21 September 2017
Accepted 28 September 2017
Accepted Preprint published online 28 September 2017
